Catherine Jacobson - 24 May 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
24 May 2023
Transactions value $
$0
Form type
4
Filing time
26 May 2023, 16:25:38 UTC
Previous filing
23 Feb 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +6,726 +1.75% 10,566 24 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -6,726 -100% $0* 0 24 May 2023 Common Stock 6,726 Direct F2, F3
transaction TDOC Restricted Stock Units Award $0 +9,834 $0 9,834 25 May 2023 Common Stock 9,834 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On May 26, 2022, the reporting person was granted 6,726 restricted stock units, vesting in full on May 24, 2023.
F4 The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders.